COVID-19 vaccine stocks may go out of date as demand has dipped below supply, according to the globe’s largest manufacturer of jabs. Adar Poonawalla, chief executive of the Serum Institute of India, on Sunday said the world had stockpiled more COVID-19 jabs than it can use as some of the developing countries are not placing…
World’s Vaccine Stocks May Expire as Supply Higher Than Demand
World’s Vaccine Stocks May Expire as Supply Surpasses Demand
COVID-19 vaccine stocks may go out of date as demand has dipped below supply, according to the globe’s largest manufacturer of jabs. Adar Poonawalla, chief executive of the Serum Institute of India, on Sunday said the world had stockpiled more COVID-19 jabs than it can use as some of the developing countries are not placing…
Australia’s First mRNA Vaccine Could Be Effective in Fighting Off Omicron
Scientists in the Australian state of Victoria have come up with the nation’s first mRNA vaccine, which could effectively combat new COVID-19 variants, including Omicron. The new vaccine, developed by Monash University’s Monash Institute of Pharmaceutical Sciences (MIPS), pharmaceutical manufacturer IDT Australia, and the Doherty Institute, was created in Melbourne within five months. This vaccine has…
Japanese Yen Jumps While Dollar Dives on Pessimistic Vaccine Outlook
The Japanese yen jumped toward 113 against the U.S. dollar on Tuesday while the greenback slid against its rivals after Moderna CEO Stephane Bancel said COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the CCP virus as they have been with other types. In an interview published on Tuesday, Bancel said he predicts…
Moderna CEO Says New COVID-19 Vaccines May be Need to Counter Omicron
Moderna CEO Stéphane Bancel said in an interview published on Tuesday that he predicts current COVID-19 vaccines will be far less effective against the Omicron variant due to the high number of mutations on the spike protein. “There is no world, I think, where [the effectiveness] is the same level … we had with Delta,” Bancel…
Moderna CEO Says New COVID-19 Vaccines May be Needed to Counter Omicron
Moderna CEO Stéphane Bancel said in an interview published on Tuesday that he predicts current COVID-19 vaccines will be far less effective against the Omicron variant due to the high number of mutations on the spike protein. “There is no world, I think, where [the effectiveness] is the same level … we had with Delta,” Bancel…
Biden Says Plan is Being Put in Place for Updated Vaccines ‘Just in Case’
President Joe Biden addressed concerns surrounding the latest Chinese Communist Party (CCP) virus variant on Nov. 29, saying the U.S. is putting together a contingency plan in the event updated vaccines and boosters are needed. Biden says the Omicron variant—first identified last week in South Africa—is “a cause for concern, not a cause for panic.”…
LIVE: Texas COVID-19 Summit: Are COVID-19 Vaccines Safe and Effective?
Experts in the medical profession will provide answers on the safety and effectiveness of COVID-19 vaccines and safe and effective options for treatment. The experts will present data-supported information about early treatment and prevention of COVID-19. Join the LIVE summit Nov. 21, from 3:00pm to 7:00pm EST. Speakers: Dr. Peter McCullough Dr. Bryan Ardis Dr….
Texas COVID-19 Summit: Are COVID-19 Vaccines Safe and Effective?
Experts in the medical profession will provide answers on the safety and effectiveness of COVID-19 vaccines and safe and effective options for treatment. The experts will present data-supported information about early treatment and prevention of COVID-19. Join the LIVE summit Nov. 21, from 3:00pm to 7:00pm EST. Speakers: Dr. Peter McCullough Dr. Bryan Ardis Dr….
Pfizer, BioNTech, Moderna Making $1,000 Every Second From COVID-19 Vaccines: People’s Vaccine Alliance
Pfizer, BioNTech, and Moderna are making thousands of dollars in combined profits every minute from their COVID-19 vaccines, while less than 1 percent of each company’s doses have gone to the world’s poorest countries, according to a new analysis by the People’s Vaccine Alliance (PVA). PVA, a coalition of organizations campaigning for wider access to COVID-19 vaccines, based its calculations…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`